Neutrophilic Cell-Free Exudate Induces Antinociception Mediate by the Protein S100A9
Calcium-binding protein S100A9 (MRP-14) induces antinociceptive effect in an experimental model of painful sensibility and participates of antinociception observed during neutrophilic peritonitis induced by glycogen or carrageenan in mice. In this study, the direct antinociceptive role of the protei...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2006-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/MI/2006/36765 |
Summary: | Calcium-binding protein S100A9 (MRP-14) induces
antinociceptive effect in an experimental model of
painful sensibility and participates of antinociception observed
during neutrophilic peritonitis induced by glycogen or carrageenan
in mice. In this study, the direct antinociceptive role of the
protein S100A9 in neutrophilic cell-free exudates obtained of mice
injected with glycogen was investigated. Mice were
intraperitoneally injected with a glycogen solution, and after
4, 8, 24, and 48 hours, either the pattern of cell
migration of the peritoneal exudate or the nociceptive response of
animals was evaluated. The glycogen-induced neutrophilic
peritonitis evoked antinociception 4 and 8 hours after inoculation of the irritant. Peritoneal cell-free exudates,
collected in different times after the irritant injection, were
transferred to naive animals which were submitted to the
nociceptive test. The transference of exudates also induced
antinociceptive effect, and neutralization of S100A9 activity by
anti-S100A9 monoclonal antibody totally reverted this response.
This effect was not observed when experiments were made 24 or
48 hours after glycogen injection. These results clearly
indicate that S100A9 is secreted during glycogen-induced
neutrophilic peritonitis, and that this protein is responsible by
antinociception observed in the initial phase of inflammatory
reaction. Thus, these data reinforce the hypothesis that the
calcium-binding protein S100A9 participates of the endogenous
control of inflammatory pain. |
---|---|
ISSN: | 0962-9351 1466-1861 |